eMedicine Specialties > Radiology > Musculoskeletal

Fibrous Dysplasia

Author: Mahesh Kumar Neelala Anand, MBBS, DNB, FRCR, Clinical Director, Consultant Radiologist, Department of Radiology, Pennine Acute Hospitals NHS Trust, Manchester, UK
Contributor Information and Disclosures

Updated: Jul 29, 2009

Introduction

Background

Fibrous dysplasia is a skeletal developmental anomaly of the bone-forming mesenchyme that manifests as a defect in osteoblastic differentiation and maturation. Virtually any bone in the body can be affected. It is a nonhereditary disorder of unknown cause.1,2,3,4,5,6,7,8

Image shows homogeneous loss of the normal trabec...

Image shows homogeneous loss of the normal trabecular pattern in the shaft of the humerus, with a ground-glass appearance caused by fibrous dysplasia.

Image shows homogeneous loss of the normal trabec...

Image shows homogeneous loss of the normal trabecular pattern in the shaft of the humerus, with a ground-glass appearance caused by fibrous dysplasia.



Axial bone-window CT scan shows a bony mass that ...

Axial bone-window CT scan shows a bony mass that expands the ethmoidal sinuses; this finding is consistent with fibrous dysplasia. Note the relative homogeneous attenuation of the lesion.

Axial bone-window CT scan shows a bony mass that ...

Axial bone-window CT scan shows a bony mass that expands the ethmoidal sinuses; this finding is consistent with fibrous dysplasia. Note the relative homogeneous attenuation of the lesion.



T1-weighted axial MR scan showing low signal with...

T1-weighted axial MR scan showing low signal within the shaft of right femur in a patient with fibrous dysplasia.

T1-weighted axial MR scan showing low signal with...

T1-weighted axial MR scan showing low signal within the shaft of right femur in a patient with fibrous dysplasia.


Recent studies

Macdonald-Jankowski evaluated the features of fibrous dysplasia by systematic review of 31 reports and 788 cases. All cases were confirmed fibro-osseous lesions histopathologically. Fibrous dysplasia was found to affect males and females equally, but it was 50% more prevalent in the maxilla. The mean age at first presentation was 24 years, and the greatest frequency occurred in the second decade; in this group, males accounted for 63% of cases. The primary symptom in 90% cases was swelling, including deformation of the jaw. All cases displayed buccolingual expansion; all mandibular cases exhibited downward displacement of the lower border of the mandible; and almost all maxillary cases involved the maxillary antrum.1

Ziadi et al retrospectively studied 18 cases of craniofacial fibrous dysplasia diagnosed between 1990 and 2005 and found that most cases of craniofacial dysplasia were monostotic (94%). Only one case was polyostotic. The maxilla and the mandible were found to be the most frequent locations (83.3%). The patients' mean age was 28.6 years, ranging from 6-30 years, and the ratio of males to females was 1:3.5.9

Rahman et al studied the clinical features and management outcomes of 42 patients with craniofacial fibrous dysplasia. Out of the 42 patients, 37 had unilateral involvement and 5 had bilateral involvement, of which 3 had McCune-Albright syndrome. The most common presenting symptom was facial asymmetry (36 cases), with the frontal bone being most commonly involved (27 cases), followed by the sphenoid bone (24 cases). The most common pattern of bone involvement was monostotic (32 cases). There was optic canal involvement in 18 eyes of 15 patients, with optic atrophy in 9 eyes of 7 patients. Surgical intervention was performed in 30  cases, for both functional and reconstructive reasons. Optic canal decompression was performed in 3 cases, with stabilization of vision achieved in all cases; no patients lost vision as a result of surgery.10

Valentini et al studied the results of conservative and surgical treatment for craniomaxillofacial fibrous dysplasia in 68 patients from 1980 to 2002. Sixty-one patients had radical excision, 6 received conservative treatment, and 1 patient with mandibular involvement received radical excision and immediate reconstruction with a free fibula flap. The authors concluded that in most cases of monostotic or monofocal fibrous dysplasia of the craniofacial region, surgical techniques allow an aggressive but definitive treatment with good functional and aesthetic results. The authors noted that they perform radical treatment even in cases involving the maxilla and mandible and prefer a conservative approach only in polyostotic cases and cases of McCune-Albright syndrome.11

Pathophysiology

In fibrous dysplasia, the medullary bone is replaced by fibrous tissue, which appears radiolucent on radiographs, with the classically described ground-glass appearance. Trabeculae of woven bone contain fluid-filled cysts that are embedded largely in collagenous fibrous matrix, which contributes to the generalized hazy appearance of the bone.

The following 4 disease patterns are recognized:

  • Monostotic form
  • Polyostotic form
  • Craniofacial form
  • Cherubism

Mortality/Morbidity

Usually, fibrous dysplasia is not a fatal disease. A small percentage of patients die when the bone lesion is complicated by malignant change.12

Race

No specific racial predilection exists.

Sex

The incidence rates are equal in males and females.

Age

The initial manifestations of fibrous dysplasia are most commonly found in persons aged 3-15 years.

  • Two thirds of patients with polyostotic disease are asymptomatic before they are aged 10 years.
  • With monostotic disease, patients as old as 20 or 30 years are asymptomatic.

Presentation

Clinical findings of increasing pain and an enlarging soft tissue mass suggest malignant change. Clinical details of the 4 forms of fibrous dysplasia, as well as other features, are discussed below.2,4,5,12

Monostotic form

Approximately 70-80% of fibrous dysplasias are monostotic. This form most frequently occurs in the rib (28%), femur (23%), tibia or craniofacial bones (10-25%), humerus, and vertebrae, in decreasing order of frequency.

This form may present with pain or a pathologic fracture in patients aged 10-70 years, but this form most frequently occurs in those aged 10-30 years. The degree of bone deformity of the monostotic form is relatively less severe than that of the polyostotic type. No clearly documented evidence supports conversion of the monostotic form to the polyostotic form.

Polyostotic form

Approximately 20-30% of fibrous dysplasias are polyostotic. Polyostotic fibrous dysplasia more frequently involves the skull and facial bones, pelvis, spine, and shoulder girdle. The sites of involvement are the femur (91%), tibia (81%), pelvis (78%), ribs, skull and facial bones (50%), upper extremities, lumbar spine, clavicle, and cervical spine, in decreasing order of frequency. The dysplasia may be unilateral or bilateral, and it may affect several bones of a single limb or both limbs with or without axial skeleton involvement. Although the polyostotic variety tends to occur in a unilateral distribution, involvement is asymmetric and generalized when disease is bilateral.

Two thirds of patients are symptomatic before they are 10 years of age. Often, the initial symptom is pain in the involved limb associated with a limp, a spontaneous fracture, or both. In one series, pathologic fracture was present in 85% of polyostotic fibrous dysplasias. Leg-length discrepancy of varying degrees occurs in about 70% of patients with limb involvement. The structural integrity of the bone is weakened, and the weight-bearing bones become bowed. The curvature of the femoral neck and proximal shaft of the femur markedly increase because a femoral lesion commonly causes a severe coxa vara abnormality, shepherd's-crook deformity, which is a characteristic sign of the disease. Overgrowth of adjacent soft tissues may be present.

Craniofacial form

This pattern of the disease occurs in 10-25% of patients with the monostotic form and in 50% with the polyostotic form. It also occurs in an isolated craniofacial form. In the isolated variety, no extracranial lesions are present. Sites of involvement most commonly include the frontal, sphenoid, maxillary, and ethmoidal bones. The occipital and temporal bones are less commonly affected.

Hypertelorism, cranial asymmetry, facial deformity (ie, leontiasis ossea), visual impairment, exophthalmos, and blindness may occur because of involvement of orbital and periorbital bones. Involvement of the sphenoid wing and temporal bones may result in vestibular dysfunction, tinnitus, and hearing loss. When the cribriform plate is involved, hyposmia or anosmia may result.

Cherubism

This special variant of fibrous dysplasia is an autosomal dominant disorder of variable penetrance. It occurs in children and is more severe in boys. Regression may occur after adolescence. The jaw is broad and protruding. Involvement of the maxilla and that of the mandible are symmetric.

Other features

Fibrous dysplasia may be associated with endocrinopathies in 2-3% of cases; these include precocious puberty in girls, hyperthyroidism, hyperparathyroidism, acromegaly, diabetes mellitus, and Cushing syndrome. McCune-Albright syndrome may be associated with hyperthyroidism and, hence, exophthalmos.

The prevalence rate of scoliosis in patients with polyostotic fibrous dysplasia is 40-52%. Most spinal lesions are located in the lumbar and thoracic spines, with very few located in the sacrum and cervical spine. The posterior elements of vertebrae are involved in 71%. In a series of 62 patients studied by Leet et al (2004), 40% had scoliosis and 48% had no scoliosis.

Sexual precocity in girls, with polyostotic fibrous dysplasia and cutaneous pigmentation, constitutes McCune-Albright syndrome. Cutaneous pigmentation is the most common extraskeletal manifestation in fibrous dysplasia. It occurs in more than 50% of cases of the polyostotic form. Cutaneous pigmentation in polyostotic fibrous dysplasia is ipsilateral to the side of bony lesions, a feature that differentiates this disease from pigmentation in neurofibromatosis.

The pigmented macules, or cafe-au-lait spots, are related to increased amounts of melanin in the basal cells of the epidermis. They tend be arranged in a linear or segmental pattern near the midline of the body, usually overlying the lower lumbar spine, sacrum, buttocks, upper back, neck, and shoulders. Similar lesions may occur on the lips and oral mucosa. Pigmentation may occur at birth, and in fact, it occasionally precedes the development of skeletal and endocrine abnormalities.

The only significant laboratory abnormality is an elevated alkaline phosphatase level.

Preferred Examination

Plain radiography is the first-line study. Usually, the diagnosis is straightforward when typical features are present. CT may be required to assess complex regions such as the spine, pelvis, chest, and facial skeleton. Bone scintigraphy has a limited role in the detection of subtle pathologic fractures. In fibrous dysplasia, the features on a bone scan are nonspecific for diagnostic purposes. MRI may be necessary to assess cord compression when the spine is involved.

Differential Diagnoses

Enchondroma and Enchondromatosis
Hemangioma, Bone
Eosinophilic Granuloma, Skeletal
Hyperparathyroidism, Primary
Fibrous Cortical Defect and Nonossifying Fibroma
Neurofibromatosis Type 1
Giant Cell Tumor
Paget Disease

Other Problems to Be Considered

Metastases

More on Fibrous Dysplasia

Overview: Fibrous Dysplasia
Imaging: Fibrous Dysplasia
Follow-up: Fibrous Dysplasia
Multimedia: Fibrous Dysplasia
References
Further Reading

References

  1. Macdonald-Jankowski D. Fibrous dysplasia: a systematic review. Dentomaxillofac Radiol. May 2009;38(4):196-215. [Medline].

  2. Harris WH, Dudley HR, Barry RJ. The natural history of fibrous dysplasia. An orthopaedic, pathological, and roentgenographic study. J Bone Joint Surg Am. Mar 1962;44-A:207-33.

  3. Leet AI, Magur E, Lee JS, et al. Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis. J Bone Joint Surg Am. Mar 2004;86-A(3):531-7.

  4. Lichenstein L, Jaffe HL. Fibrous dysplasia of bone: a condition affecting one, several or many bones, the graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. Arch Pathol. 1942;33:777.

  5. National Institutes of Health. Osteoporosis and Related Bone Disorders-National Resource Center Web site. Fast Facts on Fibrous Dysplasia page. Available at: http://www.osteo.org/default.asp. Washington, DC: National Institutes of Health;2001. [Full Text].

  6. Resnick D, Niwayama G. Diagnosis of Bone and Joint Disorders. 2nd ed. Philadelphia, Pa: WB Saunders;. 1988: 4057-70.

  7. Kruse A, Pieles U, Riener MO, Zunker Ch, Bredell MG, Grätz KW. Craniomaxillofacial fibrous dysplasia: a 10-year database 1996-2006. Br J Oral Maxillofac Surg. Jun 2009;47(4):302-5. [Medline].

  8. Mancini F, Corsi A, De Maio F, Riminucci M, Ippolito E. Scoliosis and spine involvement in fibrous dysplasia of bone. Eur Spine J. Feb 2009;18(2):196-202. [Medline].

  9. Ziadi S, Trimeche M, Mokni M, Sriha B, Khochtali H, Korbi S. [Eighteen cases of craniofacial fibrous dysplasia.]. Rev Stomatol Chir Maxillofac. Jul 15 2009;[Medline].

  10. Rahman AM, Madge SN, Billing K, Anderson PJ, Leibovitch I, Selva D, et al. Craniofacial fibrous dysplasia: clinical characteristics and long-term outcomes. Eye. Jan 30 2009;[Medline].

  11. Valentini V, Cassoni A, Marianetti TM, Terenzi V, Fadda MT, Iannetti G. Craniomaxillofacial fibrous dysplasia: conservative treatment or radical surgery? A retrospective study on 68 patients. Plast Reconstr Surg. Feb 2009;123(2):653-60. [Medline].

  12. Schwartz DT, Alpert M. The malignant transformation of fibrous dysplasia. Am J Med Sci. Jan 1964;247:1-20. [Medline].

  13. Lädermann A, Stern R, Ceroni D, De Coulon G, Taylor S, Kaelin A. Unusual radiologic presentation of monostotic fibrous dysplasia. Orthopedics. Mar 2008;31(3):282. [Medline].

  14. Bulakbasi N, Bozlar U, Karademir I, Kocaoglu M, Somuncu I. CT and MRI in the evaluation of craniospinal involvement with polyostotic fibrous dysplasia in McCune-Albright syndrome. Diagn Interv Radiol. Dec 2008;14(4):177-81. [Medline].

  15. Sood A, Raman R, Jhobta A, Dhiman DS, Seam RK. Normal technetium-99m-MDP uptake in fibrous dysplasia of the hip. Hell J Nucl Med. Jan-Apr 2009;12(1):72-3. [Medline].

  16. Bonekamp D, Jacene H, Bartelt D, Aygun N. Conversion of FDG PET activity of fibrous dysplasia of the skull late in life mimicking metastatic disease. Clin Nucl Med. Dec 2008;33(12):909-11. [Medline].

  17. Daffner RH, Kirks DR, Gehweiler JA Jr, Heaston DK. Computed tomography of fibrous dysplasia. AJR Am J Roentgenol. Nov 1982;139(5):943-8. [Medline].

  18. De Smet A, Travers H, Neff JR. Chondrosarcoma occurring in a patient with polyostotic fibrous dysplasia. Skeletal Radiol. 1981;7:197.

  19. King RM, Payne WS, Olafsson S, Unni KK. Surgical palliation of respiratory insufficiency secondary to massive exuberant polyostotic fibrous dysplasia of the ribs. Ann Thorac Surg. Feb 1985;39(2):185-7.

Keywords

fibrous dysplasia, Lichtenstein-Jaffe's disease, Lichtenstein-Jaffe disease, McCune-Albright's disease, McCune-Albright disease, fibrous osteodystrophy, osteodystrophia fibrosa, osteitis fibrosa disseminata, monostotic form, polyostotic form, craniofacial form, cherubism

Contributor Information and Disclosures

Author

Mahesh Kumar Neelala Anand, MBBS, DNB, FRCR, Clinical Director, Consultant Radiologist, Department of Radiology, Pennine Acute Hospitals NHS Trust, Manchester, UK
Mahesh Kumar Neelala Anand, MBBS, DNB, FRCR is a member of the following medical societies: British Medical Association, British Society of Interventional Radiology, Radiological Society of North America, and Royal College of Radiologists
Disclosure: Nothing to disclose.

Medical Editor

Michael A Bruno, MD, Associate Professor, Departments of Radiology and Medicine, Pennsylvania State University College of Medicine; Director, Radiology Quality Management Services, Milton S Hershey Medical Center, Pennsylvania State University College of Medicine
Michael A Bruno, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, Association of University Radiologists, Radiological Society of North America, Society of Nuclear Medicine, and Society of Skeletal Radiology
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

Murali Sundaram, MBBS, FRCR, FACR, Consulting Staff, Department of Diagnostic Radiology, The Cleveland Clinic Foundation
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Felix S Chew, MD, MBA, EdM, Professor, Department of Radiology, Vice Chairman for Radiology Informatics, Section Head of Musculoskeletal Radiology, University of Washington
Felix S Chew, MD, MBA, EdM is a member of the following medical societies: American Roentgen Ray Society, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.